Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy
A new research perspective titled "The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy" has been published in Oncotarget.
Feb 7, 2023
0
2